Overview
Emmanuelle Trombe, Bertrand Delafaye, Noëmie Fort and Pierre Menegaux advised French biopharmaceutical company DBV Technologies on the largest secondary Nasdaq offering of the year, a public offering of new shares is in the form of American Depositary Shares (ADSs) in the United States for $ 281.5 million. The shares are also listed on Euronext Paris.
